Skip to main content
Fig. 10 | Biomaterials Research

Fig. 10

From: Emerging biomaterials for tumor immunotherapy

Fig. 10

Schematic diagram of PEG-b-PAsp-g-PBE/TRP2 for tumor immunotherapy. A Schematic diagram of the nanovaccine delivery system PEG-b-PAsp-g-PBE/TRP2. B Antitumor effect of PEG-b-PAsp-g-PBE/TRP2 vaccine against B16F10 melanoma cells. (a) average tumor growth curves. (b) Survival data of mice. (c, d) The representative flow cytometry images and statistic data of (c) CD8.+ T cells and (d) Treg cells in the spleen at the end of the study. (Reproduced with permission from [102] Copyright © 2022, Drug Delivery)

Back to article page